Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenues, net $ 2,906,771 $ 2,163,719
Cost of goods sold 1,810,942 1,236,051
Gross profit 1,095,829 927,668
Operating expenses:    
General and administration 11,781,503 7,641,234
Sales and marketing 1,487,394 1,223,767
Research and development 5,800,549 3,586,553
Total operating expenses 19,069,446 12,451,554
Operating loss (17,973,617) (11,523,886)
Other income    
Other income 591,900 20,209
Interest income 11,578 251
Interest expense (575,685) (1,936,847)
Change in fair value of derivative liability (37,607)
Total other income (expense), net 27,793 (1,953,994)
Loss before benefit from income taxes (17,945,824) (13,477,880)
Benefit from income taxes 2,921,982
Net loss $ (15,023,842) $ (13,477,880)
Net loss per share - basic and diluted (in Dollars per share) $ (0.44) $ (0.66)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 34,180,897 20,428,490